(E)-Cyclooct-2-en-1-yl (4-nitrophenyl) carbonate, 97.0%, 250mg

2,4,6-Triphenylpyridine, 98%, 100g

Ethyl 2-(pyrimidin-4-yl)acetate, 95.0%, 10g

Methyl 4-chlorocinnamate, 95.0%, 1g

4-Hydroxy-3-nitrophenylacetic Acid>98.0%(T)1g

Methyl 5-bromo-2-(chlorosulfonyl)benzoate, 95%, 5g

m-Tolylhydrazine hydrochloride, 98.0%, 25g

Plan stress-free PLPOLi 20x/0.40 IOS objective for iScope incident polarization, no cover glass correction. Working distance 5.8 mm

(R)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropanoic acid, 95.0%, 1g

(2E)-3-(4-bromophenyl)-1-phenylprop-2-en-1-one, 95.0%, 2g

(4-Cyanopyridin-3-yl)boronic acid, 98+%, 250mg

2,6-Dibromo-3-chloro-4-methylaniline, 95.0%, 100g

1-OXA-6-AZASPIRO[3.4]OCTANE HEMIOXALATE, 95.0%, 500mg